Articles from BIOTECH Patent News (July 1, 2004)

1-30 out of 30 article(s)

Title	Type	Words
AIDS Healthcare Foundation protests GlaxoSmithKline over voluntary licensing agreements with South African generic makers.		337
Amano obtains United States patent.	Brief Article	150
Atrix licenses BEMA technology to Arius.		436
Aventis obtains United States patent.	Brief Article	35
Aventis to move forward with reissuance process for contested Lovenox patent.		504
Chromos completes acquisition of CellExSys.		386
DNAPrint genomics and ReliaGene enter into agreement.		962
Erasmus MC to use Affymetrix technology in comprehensive translational medicine initiative large-scale RNA and DNA profiling studies set to improve patient care for wide range of diseases.		720
Gen-Probe granted summary judgment in Enzo patent lawsuit.	Brief Article	236
Genetronics builds United States patent portfolio for electroporation-assisted therapies.		406
GenoMed and Italian NIH to collaborate in finding a cure for bird flu in poultry.		326
KaloBios in-licenses rheumatoid arthritis drug from Ludwig Institute.		550
Korea Kumhoobtains United States patent.	Brief Article	65
Lexicon Genetics and Takeda establish collaboration to develop new drugs for high blood pressure.		639
Louisiana State University and Bionomics sign cancer gene therapy agreement.		969
LTA Resources obtains United States patent.	Brief Article	48
Metabasis announces issuance of a key patent covering its HepDirect liver targeting prodrug technology.		571
Monsanto requests termination of Syngenta's Roundup Ready soybean license based on breach of contract lawsuits also filed challenging Syngenta's access to Monsanto's Roundup Ready corn.		341
New Venture Gear obtains United States patent.	Brief Article	69
Peregrine licenses additional intellectual property for its anti-phospholipid therapy platform technology.		821
Rhode Island Hospital obtains United States patent.	Brief Article	37
Suntory obtains United States patent.	Brief Article	88
Takara Shuzo obtains United States patent.	Brief Article	161
Targeted Genetics expands AAV patent portfolio, has exclusive rights to newly issued AAV1 patent.		534
University of Michigan obtains United States patent.	Brief Article	76
US Surgical and Applied Medical patent trial concludes.	Brief Article	260
Viragen granted United States patent for manufacture of Multiferon.		470
Viragen licenses Oxford BioMedica's LentiVector gene delivery system for use in Avian Transgenics biomanufacturing program.		654
Wyeth obtains United States patent.	Brief Article	168
Yugengaisha Chima obtains United States patent.	Brief Article	172